EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Yttrium-90 Radioembolization Through Parasitized Extra-Hepatic Arteries in Hepatocellular Carcinoma: A Comprehensive Review

Areeb Siddiqui, Joshua D. Kuban, Shams Iqbal, Kiyon Naser-Tavakolian, Tarub S. Mabud, Abin Sajan, Ryan M. Hickey, Kirema Garcia-Reyes, Junaid Raja, Maarten L. J. Smits, Mina S. Makary, Venkatesh P. Krishnasamy

Current Oncology · 14.11.2026 · 33 (11) · 706

DOI: 10.3390/curroncol33110706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 14.11.2026. Verfasst von Areeb Siddiqui und 11 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) often recruits an arterial blood supply from parasitized extra-hepatic vessels. Yttrium-90 (Y-90) radioembolization can be delivered directly through these vessels as an alternative to embolizing them to redistribute flow. This comprehensive review describes the feasibility, safety, and reported tumor response of that approach. PubMed, Embase, and Scopus were searched to June 2026, and outcomes were summarized descriptively. We included five retrospective cohorts (109 reported participants) and six case reports. All five cohorts were at serious risk of bias. The studies reported delivery through the inferior phrenic, cystic, adrenal, internal mammary, and superior mesenteric arteries. Delivery through the extra-hepatic artery was completed in every treated patient. In the four cohorts reporting tumor response, the objective response ranged from 68% to 100% and complete response from 21.1% to 76.5%, with wide confidence intervals, but nearly all patients also received hepatic-artery Y-90, so response cannot be attributed to the extra-hepatic route alone. Grade ≥ 3 toxicity occurred in 5.0% and 7.0% of patients in the two cohorts reporting it, and no radioembolization-induced liver disease was reported. No study compared direct delivery with flow redistribution, so the evidence supports feasibility and preliminary safety in selected patients rather than efficacy, and comparative studies with standardized dosimetry and reporting may be helpful.

Zitieren

APA

Siddiqui, A., Kuban, J. D., Iqbal, S., Naser-Tavakolian, K., Mabud, T. S., Sajan, A., Hickey, R. M., Garcia-Reyes, K., Raja, J., Smits, M. L. J., Makary, M. S., & Krishnasamy, V. P. (2026). Yttrium-90 Radioembolization Through Parasitized Extra-Hepatic Arteries in Hepatocellular Carcinoma: A Comprehensive Review. Current Oncology, 33(11), 706. https://doi.org/10.3390/curroncol33110706

Vancouver

Siddiqui A, Kuban JD, Iqbal S, Naser-Tavakolian K, Mabud TS, Sajan A, et al. Yttrium-90 Radioembolization Through Parasitized Extra-Hepatic Arteries in Hepatocellular Carcinoma: A Comprehensive Review. Current Oncology. 2026;33(11):706. doi:10.3390/curroncol33110706

BibTeX
@article{Siddiqui2026,
  author = {Siddiqui, Areeb and Kuban, Joshua D. and Iqbal, Shams and Naser-Tavakolian, Kiyon and Mabud, Tarub S. and Sajan, Abin and Hickey, Ryan M. and Garcia-Reyes, Kirema and Raja, Junaid and Smits, Maarten L. J. and Makary, Mina S. and Krishnasamy, Venkatesh P.},
  title = {Yttrium-90 Radioembolization Through Parasitized Extra-Hepatic Arteries in Hepatocellular Carcinoma: A Comprehensive Review},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {11},
  pages = {706},
  doi = {10.3390/curroncol33110706}
}
Kostenlos starten →